Industries de la santé
22 Octobre 2012
LONDON, UK (GlobalData), 22 October 2012 - The 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) played host to promising data that aim to address one of the greatest unmet needs in Multiple Sclerosis (MS): the treatment for progressive forms of the disease. Although Primary-Progressive MS (PPMS) afflicts only 10%–15% of the MS... |Plus d'articles...
- Pluristem Receives Approval to Commence a Phase I/II Study for Muscle Regeneration in Germany
- Fragile X and Down syndromes share signalling pathway for intellectual disability
- Intelligent Design: IntelligentMDx’s New Herpes Diagnostic Test Receives EU Approval
- Pluristem Partners with CPC Clinical Research for Peripheral Artery Disease Study